Bionano Genomics Inc. Bionano Genomics NASDAQBNGO.
Genome Mapping Systems Bionano Genomics
BNGO shares have gone up 101045 during the last six months with a year-to-date growth rate more than the industry average at 5128 against 95.
Bionano genomics news. In the rating firms projections revenue. NASDAQBNGO went up by 2245 from its latest closing price compared to the recent 1-year high of 1569. Bionano Genomics veröffentlichte am 14052021 auf der all-dreimonatlichen Finanzkonferenz die Zahlen zum am 31032021 abgelaufenen Jahresviertel.
Unfassbar jetzt winkt der nächste Schrittliegt Bionano Genomics damit 96897 Prozent über dem Durchschnitt 1551 Prozent. Bionano Genomics wird am 13052021 die Bilanz zum am 31032021 abgelaufenen Quartal präsentieren. Bionano Genomics Inc.
Per daher hab ich keinen Rasen Lesen Sie die neusten Einträge im Bionano Genomics-Forum und diskutieren Sie. The new note on the price target was released on April 08 2020 representing the official price target for Bionano Genomics Inc. Revenue of 317M 1781 YY beats by 02M.
Bionano Genomics lost a lot of supporters in recent months and some never came to the rescue but a lifeline has been thrown to BNGO stock. Bionano Genomics BNGO new study is likely to lead to a new level of cancer research and drug discovery with reduced side effects demonstrating the importance of optical genome mapping OGM. BIONANO GENOMICS A2JRLZ US09075F1075 mit aktuellem Aktienkurs Charts News und Analysen.
US09075F1075 Kurs mit Realtime Chart Alle Entwicklungen Kommentare und News auf BörsenNEWSde live verfolgen. Die mittlere jährliche Rendite für Wertpapiere aus der gleichen Branche Life Sciences Werkzeuge. The company sold more.
The primary key to Bionanos first-quarter success was increased demand for its reagent rental program and consumables. BNGO announced today the publication of a study that analyzed the. 16 Zeilen News zur BIONANO GENOMICS AKTIE und aktueller Realtime-Aktienkurs Bionano Genomics to Present at the 2021 Oppenheimer MedTech Tools Diagnostic Summit.
The Average True Range ATR for Bionano Genomics Inc. Is set at 066 with the Price to Sales ratio for BNGO stock in the period of the last 12 months amounting to 14465. Yet analysts are ramping up their growth forecast for the fiscal year 2021.
Die neuesten Analysen zur Bionano Genomics Aktie im Überblick alle aktuellen Nachrichten Analysen Überblicke rund um Bionano Genomics. Q1 net loss of 99M. Die Schätzungen von 2 Analysten gehen beim Ergebnis je Aktie von durchschnittlich -0045 USD aus.
Bionano Genomics Announces Publication of New Approach to Study DNA Replication Using Optical Genome Mapping With Saphyr Potentially Supporting Development of. Press Release reported on. Bionano Genomics News.
Revenue is predicted to grow 556 this quarter and then jump 50 in the quarter after that. BNGO today announced that the first. Shares of the genome analysis company jumped 35 in Fridays pre-market session.
Bionano Genomics BNGO new study is likely to lead to a. Bionano Genomics hat im. Bionano Genomics Data is Essential Part of the First Ever Complete Assembly of a Human X-Chromosome SAN DIEGO July 16 2020 -- Bionano Genomics Inc.
SAN DIEGO April 22 2021 GLOBE NEWSWIRE -- Bionano Genomics Inc. Bionano Genomics Aktie BNGO Branche. Bionano Genomics Tubbi schreibt.
Auf dieser Seite finden Sie alle Bionano Genomics News und Nachrichten zur Bionano Genomics Aktie. The companys stock price has collected -018 of loss in the last five trading sessions. At March 31 2021 the Company had cash and cash equivalents of 362 million compared to cash.
